The potassium channel Kv1.3 is highly expressed in the mitochondria of various cancerous cells. Here we show that direct inhibition of Kv1.3 using two mitochondria-targeted inhibitors alters mitochondrial function and leads to reactive oxygen species (ROS)-mediated death of even chemoresistant cells independently of p53 status. These inhibitors killed 98% of ex vivo primary chronic B-lymphocytic leukemia tumor cells while sparing healthy B cells. In orthotopic mouse models of melanoma and pancreatic ductal adenocarcinoma, the compounds reduced tumor size by more than 90% and 60%, respectively, while sparing immune and cardiac functions. Our work provides direct evidence that specific pharmacological targeting of a mitochondrial potassium channel can lead to ROS-mediated selective apoptosis of cancer cells in vivo, without causing significant side effects.
Keywords: ROS-induced apoptosis; bioenergetics; chronic lymphocytic leukemia; ion channels and cancer; mitochondrial metabolism; mitochondrial potassium channels; mitochondriotropic inhibitors; orthotopic melanoma model; pancreatic ductal adenocarcinoma; pharmacokinetics.
Copyright © 2017 Elsevier Inc. All rights reserved.